Entasis Therapeutics Holdings Stock Price, News & Analysis

ETTX NASDAQ

Company Description

Entasis Therapeutics Holdings (NASDAQ: ETTX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

ETTX stock has declined 11.2% over the past year.

This page provides a comprehensive overview of ETTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-11.16%

Performance 1 year

$0.0

Market Cap

47.9M

Shares outstanding

Entasis Therapeutics Holdings (ETTX) stock. Over the past 12 months, the stock has lost 11.2%.

Latest News

View All

October 12, 2022

—

Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022

July 8, 2022

-0.45%

Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.

June 9, 2022

-0.46%

Entasis Therapeutics Presents Data on Sulbactam-Durlobactam and ETX0462 at 2022 ASM Microbe Annual Conference

May 23, 2022

+21.11%

Innoviva to Acquire Entasis Therapeutics

acquisition

May 23, 2022

+21.11%

Innoviva to Acquire Entasis Therapeutics

acquisition

May 17, 2022

+1.14%

Entasis Therapeutics Presents Data Highlights from Phase 3 ATTACK Trial at 2022 American Thoracic Society Annual Conference

clinical trial

Entasis Therapeutics Holdings has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, clinical trial, earnings. View all ETTX news →

SEC Filings

View All

No SEC filings available for ETTX.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ETTX Company Profile & Sector Positioning

Entasis Therapeutics Holdings (ETTX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.